Uncategorized Archives - Page 13 of 14 - IPHA
September 26, 2017

IPHA launches report and infographic on how Ireland is falling behind in access to new medicines

IPHA has launched a briefing document which sets out how Irish patients are being denied access to new medicines that are readily available in other Western […]
September 22, 2017

IPHA Submission to National Biosimilar Medicines Consultation

Innovation is key for best outcomes: Ireland must adopt innovation faster No change should be made to current legislation since physicians can already prescribe  biosimilars:  pharmacy-led substitution without […]
July 28, 2017

IPHA welcomes confirmation delayed medicines will be made available for patients

Lessons must be learned from dysfunctional process Call for medicines to be available as fast as in Europe The Irish Pharmaceutical Healthcare Association welcomes the statement […]
July 17, 2017

Crunch meeting fails to clear new medicines logjam

Pharmaceutical companies are delivering huge savings but access to new medicines is worse 17/07/2017 Thousands of patients in Ireland, with serious conditions ranging from heart disease, […]
July 5, 2017

Timely reimbursement of innovative medicines important for new National Cancer Strategy

Current problems with reimbursement process needs to be overcome Wednesday 5th July 2017 The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the new National Cancer Strategy and […]
June 22, 2017

Pharmaceutical industry to deliver further saving to the State of €15 million

Prices of 780 medicines to fall on 1 July under IPHA Agreement but HSE now has no budget for new medicines despite successive price reductions 22 […]
April 27, 2017

Minister for Health launches new Irish vaccines publication to mark World Immunisation Week

Vaccines-press-release-final.pdf IPHA-Vaccines-for-Life-(1).pdf
April 21, 2017

IPHA Guidance on Direct HealthCare Professional Communication (DHPC)

The Irish Pharmaceutical Healthcare Association (IPHA) has produced a Guidance on Direct Healthcare Professional Communication (DHPC).   The multiple distribution of DHPCs by several companies for […]
April 12, 2017

IPHA welcomes decision to reimburse Cystic Fibrosis medicines

IPHA-Press-release.pdf